RedShift BioAnalytics
PrivateLast Round
Series E
Oct 18, 2021
Total Funding Raised
$70.18M
Company Overview
RedShift BioAnalytics is a life sciences company that provides a platform for biomolecule analysis through its proprietary Microfluidic Modulation Spectroscopy (MMS) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RedShift BioAnalytics Comps
Public and private peers based on sector, stage, and business model.
RedShift BioAnalytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 18, 2021 | ||||
| Series D Extension | Feb 18, 2021 | ||||
| Series D | Jan 29, 2020 | ||||
| Series C | Mar 8, 2017 | ||||
| Series B | Apr 11, 2013 | ||||
Series A | Jan 12, 2006 |
Key People
Founding team and executive leadership
RedShift BioAnalytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Technology Venture Partners | Series E, Series A, Series B, Series C, Series D Extension, Series D |
| Waters Corporation | Series D Extension, Series D, Series E, Series C |
| Illumina Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors increased 82% MoM, reaching 6.2K.
- May 3, 2025
Monthly visitors increased 48% MoM.
RedShift BioAnalytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RedShift BioAnalytics's valuation, stock price, and market status.